NCT05442060 2025-08-03
EGFR
OBI Pharma, Inc
Phase 2 Recruiting
Clinical Trials
4 trialsNCT06071013 2025-01-23
Nintedanib Plus EGFR TKI In EGFR-mutated Non-small Cell Lung Cancer Patients
China Medical University Hospital
Phase 1/2 Recruiting
NCT04322890 2024-10-22
PIKACHU
Hunan Province Tumor Hospital
Phase 2 Recruiting
NCT03192501 2024-06-25
iCAGES-guided Precision Therapy for Cancers in Contrast to Standard Care or IHC-guided Theray
Second Affiliated Hospital of Guangzhou Medical University
Recruiting